Agenda
12:30 PM ET

VolitionRx Limited
NYSE AMERICAN: VNRX
Scott Powell, Head of Investor Relations & U.S. Chief Financial Officer
1:00 PM ET

XPhyto Therapeutics Corp.
OTCQB: XPHYF | CSE: XPHY | FSE: 4XT
Hugh Rogers, CEO & Director
NYSE AMERICAN: VNRX
Scott Powell, Head of Investor Relations & U.S. Chief Financial Officer
OTCQB: XPHYF | CSE: XPHY | FSE: 4XT
Hugh Rogers, CEO & Director